Joseph W. Jackson

1.4k total citations · 1 hit paper
30 papers, 1.1k citations indexed

About

Joseph W. Jackson is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Joseph W. Jackson has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Joseph W. Jackson's work include Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Immune Cell Function and Interaction (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Joseph W. Jackson is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Immune Cell Function and Interaction (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Joseph W. Jackson collaborates with scholars based in United States, Ireland and Norway. Joseph W. Jackson's co-authors include David T. Takeuchi, Pinka Chatterji, Zhun Cao, Xiao‐Li Meng, Margarita Alegrı́a, C.-S. Chen, Tim E. Sparer, Conleth Feighery, T. P. J. Hennessy and Jane Holland and has published in prestigious journals such as The Lancet, Blood and Journal of the American College of Cardiology.

In The Last Decade

Joseph W. Jackson

28 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disparity in Depression Treatment Among Racial and Ethnic Minority Populations in the United States

2008 574 citations Margarita Alegrı́a, Pinka Chatterji et al. Psychiatric Services profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph W. Jackson United States	13	347	306	184	174	144	30	1.1k
Salvatore Zaffina Italy	20	114 0.3×	300 1.0×	236 1.3×	278 1.6×	155 1.1×	62	1.3k
Max Cooper United Kingdom	14	134 0.4×	228 0.7×	98 0.5×	167 1.0×	243 1.7×	88	1.1k
Chiung‐Yu Huang Taiwan	20	182 0.5×	238 0.8×	104 0.6×	151 0.9×	40 0.3×	49	1.1k
C. Bernal Bellido Spain	27	217 0.6×	461 1.5×	394 2.1×	196 1.1×	258 1.8×	163	3.0k
Daniel P. Krowchuk United States	23	277 0.8×	498 1.6×	307 1.7×	405 2.3×	74 0.5×	56	2.4k
Jennifer L. Marino Australia	24	138 0.4×	162 0.5×	85 0.5×	163 0.9×	100 0.7×	73	1.6k
Paul Swamidhas Sudhakar Russell India	22	116 0.3×	616 2.0×	156 0.8×	162 0.9×	109 0.8×	105	1.6k
Homer Venters United States	22	109 0.3×	519 1.7×	281 1.5×	348 2.0×	160 1.1×	64	1.5k
Janice M. Zeller United States	22	135 0.4×	152 0.5×	371 2.0×	166 1.0×	183 1.3×	53	1.6k

Countries citing papers authored by Joseph W. Jackson

Since Specialization

Citations

This map shows the geographic impact of Joseph W. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph W. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph W. Jackson more than expected).

Fields of papers citing papers by Joseph W. Jackson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph W. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph W. Jackson. The network helps show where Joseph W. Jackson may publish in the future.

Co-authorship network of co-authors of Joseph W. Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph W. Jackson. A scholar is included among the top collaborators of Joseph W. Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph W. Jackson. Joseph W. Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Foster, James S., Sallie Macy, Manasi Balachandran, et al.. (2024). Neutrophils enhance the clearance of systemic amyloid deposits in a murine amyloidoma model. Frontiers in Immunology. 15. 1487250–1487250. 1 indexed citations

Wall, Jonathan S., Michael Klein, Spencer Guthrie, et al.. (2024). The Peptide Fusion Immunoglobulin, AT-02, Exhibits Highly Potent Pan-Amyloid Reactivity And Immunomodulation. Journal of Cardiac Failure. 30(1). 210–210. 4 indexed citations

Wall, Jonathan S., Stephen J. Kennel, Alan Stuckey, et al.. (2024). Characterization of AT02 Bioactivity and an Assessment of Its Potential Use As an Amyloid-Clearing Therapeutic for AL Amyloidosis. Blood. 144(Supplement 1). 4641–4641.

Kennel, Stephen J., Joseph W. Jackson, Alan Stuckey, et al.. (2024). Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis. PLoS ONE. 19(4). e0301756–e0301756. 5 indexed citations

Wall, Jonathan S., Emily B. Martin, R. Eric Heidel, et al.. (2024). DETECTION OF AMYLOID CARDIOMYOPATHY IN PATIENTS WITH SYSTEMIC ATTR AND AL AMYLOIDOSIS USING SPECT/CT AND PLANAR IMAGING OF A TECHNETIUM-99M-LABELED PEPTIDE - TECHNETIUM-99M (99MTC) EVUZAMITIDE. Journal of the American College of Cardiology. 83(13). 1369–1369. 1 indexed citations

Foster, James S., Manasi Balachandran, Emily B. Martin, et al.. (2023). Development and characterization of a prototypic pan-amyloid clearing agent – a novel murine peptide-immunoglobulin fusion. Frontiers in Immunology. 14. 1275372–1275372. 12 indexed citations

Wall, Jonathan S., Suganya Selvarajah, James S. Foster, et al.. (2023). Characterization of AT-02, a pan-amyloid-binding peptide fusion immunoglobulin with high binding potency, complement activation, and immune cell stimulation. European Heart Journal. 44(Supplement_2).

Jackson, Joseph W., Bonnie L. Hall, Lisa Bailey, et al.. (2021). Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment. Molecular Therapy — Oncolytics. 22. 444–453. 7 indexed citations

Collier, J. Jason, Heidi M. Batdorf, Thomas M. Martin, et al.. (2020). Pancreatic, but not myeloid-cell, expression of interleukin-1alpha is required for maintenance of insulin secretion and whole body glucose homeostasis. Molecular Metabolism. 44. 101140–101140. 12 indexed citations

10.

Glorioso, Joseph C., Justus B. Cohen, William F. Goins, et al.. (2020). Oncolytic HSV Vectors and Anti-Tumor Immunity. Current Issues in Molecular Biology. 41. 381–468. 15 indexed citations

11.

Burke, Susan J., Heidi M. Batdorf, Joseph W. Jackson, et al.. (2019). One week of continuous corticosterone exposure impairs hepatic metabolic flexibility, promotes islet β-cell proliferation, and reduces physical activity in male C57BL/6 J mice. The Journal of Steroid Biochemistry and Molecular Biology. 195. 105468–105468. 13 indexed citations

12.

Jackson, Joseph W., et al.. (2019). Exposure of Candida albicans β (1,3)-glucan is promoted by activation of the Cek1 pathway. PLoS Genetics. 15(1). e1007892–e1007892. 45 indexed citations

13.

Jackson, Joseph W., Pranay Dogra, Ravit Arav‐Boger, et al.. (2019). Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of In Vitro Screenings. mSphere. 4(1). 11 indexed citations

14.

Wagner, Andrew S., et al.. (2019). Pathways That Synthesize Phosphatidylethanolamine Impact Candida albicans Hyphal Length and Cell Wall Composition through Transcriptional and Posttranscriptional Mechanisms. Infection and Immunity. 88(3). 8 indexed citations

15.

Alegrı́a, Margarita, Pinka Chatterji, Zhun Cao, et al.. (2008). Disparity in Depression Treatment Among Racial and Ethnic Minority Populations in the United States. Psychiatric Services. 59(11). 1264–1272. 574 indexed citations breakdown →

16.

González, Héctor, K Whitfield, Bruce J. West, et al.. (2007). Modified-Symbol Digit Modalities Test for African Americans, Caribbean Black Americans, and non-Latino Whites: Nationally representative normative data from the National Survey of American Life. Archives of Clinical Neuropsychology. 22(5). 605–613. 19 indexed citations

17.

Jackson, Joseph W., et al.. (1997). Ehrlichiosis with systemic sepsis syndrome.. PubMed. 90(5). 185–6. 6 indexed citations

18.

Bonnerjea, J., Joseph W. Jackson, M. Hoare, & P. Dunnill. (1988). Affinity flocculation of yeast cell debris by carbohydrate-specific compounds. Enzyme and Microbial Technology. 10(6). 357–360. 22 indexed citations

19.

Jackson, Joseph W.. (1965). CHROMOSOMES IN DYSTROPHIA MYOTONICA. The Lancet. 285(7397). 1225–1226. 6 indexed citations

20.

Jackson, Joseph W.. (1963). Detection of oxygen-17 n.m.r. in solid MgO. Journal of Physics and Chemistry of Solids. 24(5). 591–592. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact